Road from overdose crisis response to prevention requires timely data
An AMA-hosted summit of drug-OD surveillance experts explored how to obtain shareable and actionable information.
Opioid epidemic: Huge funding boost needed to close treatment gap
Administrative and insurance barriers continue to block access to treatment, AMA President-elect Susan R. Bailey, MD, tells Congress.
Lifesaving naloxone should be available almost everywhere
Publicly available naloxone rescue boxes could allow bystanders to save the lives of people experiencing opioid overdoses.
AMA strengthens its policies promoting naloxone access and education
Physicians and medical students acted today to strengthen existing AMA policy promoting increased access to naloxone, the opioid overdose-reversing drug.
Physicians take steps against opioid epidemic, mortality rises
AMA opioids report highlights limited effects of mandates to stem an epidemic underscoring the need for focus on removing barriers to evidence-based treatment.
Doctors make progress on opioids, call on policymakers to do more
Opioid prescriptions fell by 33% over five years, says 2019 AMA Opioid Task Force report. Next step: Eliminate barriers to evidence-based treatment.
AMA Opioid Task Force recommendations offer roadmap to policymakers
The AMA Opioid Task Force recommendations call on policymakers to eliminate barriers to treatment and to take additional steps to end the opioid epidemic.
AMA, NCMS, Manatt: Study of NC reversing opioid epidemic
A new report today by the AMA, North Carolina Medical Soc, and Manatt Health shows North Carolina is adopting strategies to combat the opioid epidemic.
AMA, MSMA, Manatt: Study on MS reversing opioid epidemic
A new report today by the AMA, Mississippi State Medical Assn (MSMA), and Manatt Health shows Mississippi is adopting strategies to combat the opioid epidemic.